Clinical trial
Phosphorus-32 Plus Radiation Therapy and Chemotherapy in Treating Patients With…
NCT00006212 · Center for Molecular Medicine, Other · Unknown status
Key facts
| NCT number | NCT00006212 |
|---|---|
| Title | Phosphorus-32 Plus Radiation Therapy and Chemotherapy in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer |
| Official title | Phase I Study of Interstitial Colloidal 32P Integrated With External Radiation Therapy and Chemotherapy in the Treatment of Non-Resectable or Medically Inoperable Non-Small Cell Carcinoma of the Lung |
| Lead sponsor | Center for Molecular Medicine, Other |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug, Radiation |
| Interventions | cisplatin, vinblastine sulfate, phosphorus P32, radiation therapy |
| Start date | Nov 1, 1999 |
| First posted | May 26, 2004 |
| Last update posted | Sep 17, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: